Dear reader, the pharmaceutical industry plays a crucial role in protecting human health, which necessitates stringent ...
Attention-deficit/hyperactivity disorder (ADHD) affects 3%–5% of children and about 2.5% of adults, though prevalence varies ...
Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...
Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.
Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, ...
Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, with 381 patients randomized or approved to randomize as ...
Minneapolis Mayor Jacob Frey said the officer who fatally shot a motorist acted recklessly and rejected federal officials' ...
From her early days as a cancer researcher to her role as a global cannabis advocate, Macias’ journey is one of resilience, ...
Security Matters PLC is a pre-revenue company specializing in molecular traceability and authentication tech. See why SMX ...
European decision on approval is expected by Q1 2027If approved, etripamil nasal spray is expected to offer patients a safe and effective ...
The European Commission has put forward a raft of new measures that will improve the health of Europeans and contribute to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results